BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21441009)

  • 1. Serotonin transporter gene polymorphism implicates reduced orbito-frontal cortex in obsessive-compulsive disorder.
    Atmaca M; Onalan E; Yildirim H; Yuce H; Koc M; Korkmaz S; Mermi O
    J Anxiety Disord; 2011 Jun; 25(5):680-5. PubMed ID: 21441009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volumetric MRI study of key brain regions implicated in obsessive-compulsive disorder.
    Atmaca M; Yildirim H; Ozdemir H; Tezcan E; Poyraz AK
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):46-52. PubMed ID: 16859819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse relationship between thalamic and orbitofrontal volumes in obsessive-compulsive disorder.
    Rotge JY; Dilharreguy B; Aouizerate B; Martin-Guehl C; Guehl D; Jaafari N; Langbour N; Bioulac B; Tignol J; Allard M; Burbaud P
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):682-7. PubMed ID: 19306905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of brain volume changes in obsessive-compulsive disorder.
    Rotge JY; Guehl D; Dilharreguy B; Tignol J; Bioulac B; Allard M; Burbaud P; Aouizerate B
    Biol Psychiatry; 2009 Jan; 65(1):75-83. PubMed ID: 18718575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volumetric MRI assessment of brain regions in patients with refractory obsessive-compulsive disorder.
    Atmaca M; Yildirim B H; Ozdemir B H; Aydin B A; Tezcan A E; Ozler A S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1051-7. PubMed ID: 16687198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A manual and automated MRI study of anterior cingulate and orbito-frontal cortices, and caudate nucleus in obsessive-compulsive disorder: comparison with healthy controls and patients with schizophrenia.
    Riffkin J; Yücel M; Maruff P; Wood SJ; Soulsby B; Olver J; Kyrios M; Velakoulis D; Pantelis C
    Psychiatry Res; 2005 Feb; 138(2):99-113. PubMed ID: 15766634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain morphology of patients with body dysmorphic disorder.
    Atmaca M; Bingol I; Aydin A; Yildirim H; Okur I; Yildirim MA; Mermi O; Gurok MG
    J Affect Disord; 2010 Jun; 123(1-3):258-63. PubMed ID: 19846221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orbitofrontal cortex volume in late life depression: influence of hyperintense lesions and genetic polymorphisms.
    Taylor WD; Macfall JR; Payne ME; McQuoid DR; Steffens DC; Provenzale JM; Krishnan KR
    Psychol Med; 2007 Dec; 37(12):1763-73. PubMed ID: 17335636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism.
    Wassink TH; Hazlett HC; Epping EA; Arndt S; Dager SR; Schellenberg GD; Dawson G; Piven J
    Arch Gen Psychiatry; 2007 Jun; 64(6):709-17. PubMed ID: 17548752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional gray and white matter volume abnormalities in obsessive-compulsive disorder: a voxel-based morphometry study.
    Togao O; Yoshiura T; Nakao T; Nabeyama M; Sanematsu H; Nakagawa A; Noguchi T; Hiwatashi A; Yamashita K; Nagao E; Kanba S; Honda H
    Psychiatry Res; 2010 Oct; 184(1):29-37. PubMed ID: 20833001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between obsessive-compulsive disorder and a variable number of tandem repeats polymorphism in intron 2 of the serotonin transporter gene.
    Baca-Garcia E; Vaquero-Lorenzo C; Diaz-Hernandez M; Rodriguez-Salgado B; Dolengevich-Segal H; Arrojo-Romero M; Botillo-Martin C; Ceverino A; Piqueras JF; Perez-Rodriguez MM; Saiz-Ruiz J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):416-20. PubMed ID: 17174018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of the association of serotonin transporter gene polymorphism with obsessive-compulsive disorder.
    Lin PY
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):683-9. PubMed ID: 17291658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision-making impairment is related to serotonin transporter promoter polymorphism in a sample of patients with obsessive-compulsive disorder.
    da Rocha FF; Malloy-Diniz L; Lage NV; Romano-Silva MA; de Marco LA; Correa H
    Behav Brain Res; 2008 Dec; 195(1):159-63. PubMed ID: 18603313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response.
    Di Bella D; Erzegovesi S; Cavallini MC; Bellodi L
    Pharmacogenomics J; 2002; 2(3):176-81. PubMed ID: 12082589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White matter abnormalities of fronto-striato-thalamic circuitry in obsessive-compulsive disorder: A study using diffusion spectrum imaging tractography.
    Chiu CH; Lo YC; Tang HS; Liu IC; Chiang WY; Yeh FC; Jaw FS; Tseng WY
    Psychiatry Res; 2011 Jun; 192(3):176-82. PubMed ID: 21546223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volumetric MRI study of orbito-frontal cortex and thalamus in obsessive-compulsive personality disorder.
    Atmaca M; Korucu T; Tabara MF; Yildirim H; Kılıç MC
    J Clin Neurosci; 2019 Jun; 64():89-93. PubMed ID: 30962057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of obsessive-compulsive-, panic-, obsessive-compulsive personality-, and non-disordered individuals by variation in the promoter region of the serotonin transporter gene.
    Perez M; Brown JS; Vrshek-Schallhorn S; Johnson F; Joiner TE
    J Anxiety Disord; 2006; 20(6):794-806. PubMed ID: 16303282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orbito-frontal cortex and thalamus volumes in obsessive-compulsive disorder before and after pharmacotherapy.
    Atmaca M; Mermi O; Yildirim H; Gurok MG
    Brain Imaging Behav; 2016 Sep; 10(3):669-74. PubMed ID: 26311393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional gray matter abnormalities in obsessive-compulsive disorder: a voxel-based morphometry study.
    Valente AA; Miguel EC; Castro CC; Amaro E; Duran FL; Buchpiguel CA; Chitnis X; McGuire PK; Busatto GF
    Biol Psychiatry; 2005 Sep; 58(6):479-87. PubMed ID: 15978549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of myelin oligodendrocyte glycoprotein gene and white matter volume in obsessive-compulsive disorder.
    Atmaca M; Onalan E; Yildirim H; Yuce H; Koc M; Korkmaz S
    J Affect Disord; 2010 Aug; 124(3):309-13. PubMed ID: 20452030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.